MICA enhances sensitivity to cisplatin in patients with extensive small cell lung cancer via downregulation of ABCG2

Immunotherapy utilizing natural killer cell-activated receptor natural-killer group-2 member D ligands (NKG2DLs) has had preclinical success in the treatment of small cell lung cancer. The present study aimed to investigate the association between NKG2Ls and chemoresistance. The mRNA expression of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yufeng, Tang, Hong, Si, Ruirui, Xia, Suhua, Wang, Ruilin, Wang, Qiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377106/
https://www.ncbi.nlm.nih.gov/pubmed/32724354
http://dx.doi.org/10.3892/ol.2020.11646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377106/
https://www.ncbi.nlm.nih.gov/pubmed/32724354
http://dx.doi.org/10.3892/ol.2020.11646

Ejemplares similares